Gilead Sciences Inc
LSE:0QYQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
LSE:0QYQ
|
US |
|
W
|
Winnebago Industries Inc
F:WI1
|
US |
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
Sanlorenzo SpA
MIL:SL
|
IT |
|
P
|
Pan Pacific International Holdings Corp
SWB:QJE
|
JP |
|
H
|
HSBC Holdings PLC
XMUN:HBC1
|
UK |
|
C
|
Cognizant Technology Solutions Corp
XBER:COZ
|
US |
|
U
|
USANA Health Sciences Inc
SWB:USJ
|
US |
|
Las Vegas Sands Corp
NYSE:LVS
|
US |
|
A
|
Anheuser-Busch Inbev SA
SWB:1NBA
|
BE |
|
T
|
Tokyo Gas Co Ltd
OTC:TKGSY
|
JP |
Dividends
Dividend Yield
Gilead Sciences Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Gilead Sciences Inc
0QYQ have increased by 45%.
Payout Ratio
Gilead Sciences Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 0QYQ is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0QYQ Price
Gilead Sciences Inc
| Average Annual Return | 11.85% |
| Standard Deviation of Annual Returns | 10.43% |
| Max Drawdown | -21% |
| Market Capitalization | 167B USD |
| Shares Outstanding | 1 245 850 000 |
| Percentage of Shares Shorted |
N/A
|
